Subscription Required

Only paid subscribers* to Drug Benefit News can access this Web portal with three years of back issues, searchable article archives and other valuable resources.

Subscribers to Drug Benefit News receive

  • 24 biweekly issues of timely news and insightful strategies for reducing costs and improving outcomes, delivered by First Class U.S. Mail and electronically,
  • E-News Alerts whenever important news breaks, and
  • Access to a subscriber-only Web page with:
    • Searchable archives of past articles,
    • Convenient library with PDFs of back issues,
    • Recent stories of interest grouped for convenient reading
    • Bonus reports for subscribers, and
    • Regular postings from your editor.
View a sample and get more information
September 8, 2017

Recent Stories

From Drug Benefit News - As Hurricane Irma bears down on Florida, and the Houston region confronts devastation in Hurricane Harvey’s aftermath, health plans in affected regions are taking steps to ensure that members can continue drug treatments without interruption — and in a safe and timely manner. Plans eased access to prescription drugs and health care services for members whose lives have been upended by Hurricane Harvey’s catastrophic damage to south and central Texas and beyond. Read more

CVS Health is exploring value-based management (VBM) strategies to help incentivize quality… Read more

As outcomes-based contracting gains ground, a University of Pittsburgh School of Pharmacy… Read more

As the number of opioid-related deaths soars, PBMs and payers have rolled… Read more

From the Editor

Welcome to your Drug Benefit News subscriber-only Web page

Be sure to visit often, for PDFs of issues, archives of articles and data, and more!

Please e-mail me with comments on the last issue of Drug Benefit News, story ideas for future issues or any other suggestions you have that can make the newsletter more useful for you.

August 2, 2017
CMS Unveils 2018 Standard Control Formulary

CMS will remove 17 drugs across 10 classes from its Standard Control Formulary in 2018, will launch Transform Value program in oncology, obesity, respiratory areas http://tinyurl.com/yc9uv6qd

July 31, 2017
Express Scripts Releases 2018 National Preferred Formulary

Express Scripts releases 2018 National Preferred Formulary, adding 64 drug exclusions for a total of 159. PBM says it expects employers who use the NPF will save an additional $2.5 billion next year http://tinyurl.com/y8ol9qlz

July 24, 2017
Second Biosimilar Remicade Launches

Samsung Bioepis’ Renflexis (infliximab-abda) is now available in the U.S. from Merck at a 35% discount to the wholesale acquisition cost of its reference drug, Remicade. Renflexis is second biosimilar Remicade after Inflectra (infliximab-dyyb) http://tinyurl.com/yapjoqnx

It's quick and easy to sign up for FREE access to AISHealth.com!

Why do I need to register?